FindTrial
Sign In

Efficacy of Apamarga kshara Pratisarana in the Management of Nasa Arsha ( Nasal Polyp)

Efficacy of Apamarga Kshara Pratisarana in the Management of Nasa Arsha(EhmoidalPolyp)An open labelled Single arm Clinical trial. -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043418
Enrollment
30
Registered
2022-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J330- Polyp of nasal cavity

Interventions

None listed

Sponsors

GOVERNMENT AKHANDANAND AYURVEDA COLLEGE AHMADABAD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: KSHAVATHU, NASA STRAVA, KRICHHAUCHHVASATA, SHIRAHSHULA, ANUNASIKVAKYA, NASAAVARODHA, PUTINASYA, KSHARA KARMA YOGYA, PARTIAL OR TOTAL LOSS OF SENSE OF SMELL, MOUTH BREATHING, FACIAL PAIN, POST NASAL DRIP, ETHMOIDAL POLYP

Exclusion criteria

Exclusion criteria: KSHARA KARMA AYOGYA, ENTROCHOANAL POLYP, PREGNANT WOMEN, LACTATING MOTHER, UNCONTROLLED DIABETES, HYPERTENSION, ANGIOFIBROMA, BLEEDING POLYP, MALIGNANT CONDITION OF NOSE,T.B, HIV, HEPATITES ,IMMUNODEFICIENCY CONDITION, CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Design outcomes

Primary

MeasureTime frame
LOCAL APPLICATION OF APAMARGA KSHARA PRATISARANA WILL GIVE SYMPTOMATIC RELIEF AND MAY REDUCE SIZE OF NASA ARSHATimepoint: 50 DAYS—

Secondary

MeasureTime frame
TO IMPROVE QUALITY OF NASA ARSHA PATIENT AND GIVES SHUTimepoint: 50 DAYS—

Countries

India

Contacts

Public ContactHEMANGI B SHUKLA

GOVERMENT AKHANDANAND AYURVEDA COLLEGE

dr.hemangishukla@gmail.com9825504280

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026